Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease

ABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education. Objective: We sought to assess whether some of the MoCA subtests contribute to the low accuracy of the test. Methods: We performed a cross-sectional retrospective analysis of clinical data in a cohort of 71 patients with PD, most with less than 8 years of education. Patients were examined using the MDS-UPDRS, Hoehn and Yahr and the MoCA. The data were analyzed using mainly descriptive statistics. Results: We analyzed the data of 66 patients that were not demented according to the clinical evaluation and classified them using the proposed cut-off MoCA scores for diagnosis of MCI and dementia. Thirteen patients (19.7%) were classified as having normal cognition, 24 (36.3%) MCI and 29 (43.9%) dementia. Patients with dementia had longer disease duration (p=0.016) and lower education (p=0.0001). Total MoCA scores had a an almost normal distribution with a wide range of scores and only one maximum score. Performance on the MoCA was highly correlated with education (correlation coefficient=0.66, p=0.0001). At least five of the 10 MoCA subtests showed significant floor effects. Conclusion: We believe that some of the MoCA subtests may be too difficult to be completed by PD patients with low educational level, thus contributing to the test's poor diagnostic accuracy.

Saved in:
Bibliographic Details
Main Authors: Tumas,Vitor, Borges,Vanderci, Ballalai-Ferraz,Henrique, Zabetian,Cyrus P., Mata,Ignácio F., Brito,Manuelina M.C., Foss,Maria Paula, Novaretti,Nathalia, Santos-Lobato,Bruno Lopes
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1980-57642016000400333
record_format ojs
spelling oai:scielo:S1980-576420160004003332016-12-19Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's diseaseTumas,VitorBorges,VanderciBallalai-Ferraz,HenriqueZabetian,Cyrus P.Mata,Ignácio F.Brito,Manuelina M.C.Foss,Maria PaulaNovaretti,NathaliaSantos-Lobato,Bruno Lopes MoCA validity Parkinson's disease mild cognitive impairment dementia cognitive assessment ABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education. Objective: We sought to assess whether some of the MoCA subtests contribute to the low accuracy of the test. Methods: We performed a cross-sectional retrospective analysis of clinical data in a cohort of 71 patients with PD, most with less than 8 years of education. Patients were examined using the MDS-UPDRS, Hoehn and Yahr and the MoCA. The data were analyzed using mainly descriptive statistics. Results: We analyzed the data of 66 patients that were not demented according to the clinical evaluation and classified them using the proposed cut-off MoCA scores for diagnosis of MCI and dementia. Thirteen patients (19.7%) were classified as having normal cognition, 24 (36.3%) MCI and 29 (43.9%) dementia. Patients with dementia had longer disease duration (p=0.016) and lower education (p=0.0001). Total MoCA scores had a an almost normal distribution with a wide range of scores and only one maximum score. Performance on the MoCA was highly correlated with education (correlation coefficient=0.66, p=0.0001). At least five of the 10 MoCA subtests showed significant floor effects. Conclusion: We believe that some of the MoCA subtests may be too difficult to be completed by PD patients with low educational level, thus contributing to the test's poor diagnostic accuracy.info:eu-repo/semantics/openAccessAcademia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e EnvelhecimentoDementia & Neuropsychologia v.10 n.4 20162016-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333en10.1590/s1980-5764-2016dn1004013
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Tumas,Vitor
Borges,Vanderci
Ballalai-Ferraz,Henrique
Zabetian,Cyrus P.
Mata,Ignácio F.
Brito,Manuelina M.C.
Foss,Maria Paula
Novaretti,Nathalia
Santos-Lobato,Bruno Lopes
spellingShingle Tumas,Vitor
Borges,Vanderci
Ballalai-Ferraz,Henrique
Zabetian,Cyrus P.
Mata,Ignácio F.
Brito,Manuelina M.C.
Foss,Maria Paula
Novaretti,Nathalia
Santos-Lobato,Bruno Lopes
Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
author_facet Tumas,Vitor
Borges,Vanderci
Ballalai-Ferraz,Henrique
Zabetian,Cyrus P.
Mata,Ignácio F.
Brito,Manuelina M.C.
Foss,Maria Paula
Novaretti,Nathalia
Santos-Lobato,Bruno Lopes
author_sort Tumas,Vitor
title Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_short Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_full Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_fullStr Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_full_unstemmed Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_sort some aspects of the validity of the montreal cognitive assessment (moca)for evaluating cognitive impairment in brazilian patients with parkinson's disease
description ABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education. Objective: We sought to assess whether some of the MoCA subtests contribute to the low accuracy of the test. Methods: We performed a cross-sectional retrospective analysis of clinical data in a cohort of 71 patients with PD, most with less than 8 years of education. Patients were examined using the MDS-UPDRS, Hoehn and Yahr and the MoCA. The data were analyzed using mainly descriptive statistics. Results: We analyzed the data of 66 patients that were not demented according to the clinical evaluation and classified them using the proposed cut-off MoCA scores for diagnosis of MCI and dementia. Thirteen patients (19.7%) were classified as having normal cognition, 24 (36.3%) MCI and 29 (43.9%) dementia. Patients with dementia had longer disease duration (p=0.016) and lower education (p=0.0001). Total MoCA scores had a an almost normal distribution with a wide range of scores and only one maximum score. Performance on the MoCA was highly correlated with education (correlation coefficient=0.66, p=0.0001). At least five of the 10 MoCA subtests showed significant floor effects. Conclusion: We believe that some of the MoCA subtests may be too difficult to be completed by PD patients with low educational level, thus contributing to the test's poor diagnostic accuracy.
publisher Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333
work_keys_str_mv AT tumasvitor someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT borgesvanderci someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT ballalaiferrazhenrique someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT zabetiancyrusp someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT mataignaciof someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT britomanuelinamc someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT fossmariapaula someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT novarettinathalia someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT santoslobatobrunolopes someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
_version_ 1756434484657389568